Study to Evaluate Efficacy, Safety, and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Vaccine GSK1437173A

PHASE3CompletedINTERVENTIONAL
Enrollment

1,877

Participants

Timeline

Start Date

July 13, 2012

Primary Completion Date

November 4, 2016

Study Completion Date

February 1, 2017

Conditions
Herpes Zoster
Interventions
BIOLOGICAL

Herpes Zoster vaccine GSK1437173A

2 doses administered intramuscularly (IM) in deltoid region of non-dominant arm

BIOLOGICAL

Placebo

2 doses administered IM in deltoid region of non-dominant arm

Trial Locations (178)

333

GSK Investigational Site, Taoyuan Hsien

404

GSK Investigational Site, Taichung

833

GSK Investigational Site, Kaohsiung City

1000

GSK Investigational Site, Brussels

1003

GSK Investigational Site, Grafton

1090

GSK Investigational Site, Jette

2010

GSK Investigational Site, Darlinghurst

2060

GSK Investigational Site, Antwerp

2145

GSK Investigational Site, Westmead

2193

GSK Investigational Site, Parktown

2298

GSK Investigational Site, Waratah

3000

GSK Investigational Site, Leuven

3002

GSK Investigational Site, East Melbourne

3050

GSK Investigational Site, Parkville

3084

GSK Investigational Site, Heidelberg

3128

GSK Investigational Site, Box Hill

3500

GSK Investigational Site, Hasselt

4000

GSK Investigational Site, Liège

5011

GSK Investigational Site, Woodville

6021

GSK Investigational Site, Wellington

7000

GSK Investigational Site, Hobart

8000

GSK Investigational Site, Bruges

8011

GSK Investigational Site, Christchurch

9000

GSK Investigational Site, Ghent

10021

GSK Investigational Site, New York

10117

GSK Investigational Site, Berlin

11527

GSK Investigational Site, Athens

12200

GSK Investigational Site, Berlin

12351

GSK Investigational Site, Berlin

13210

GSK Investigational Site, Syracuse

13273

GSK Investigational Site, Marseille

13419

GSK Investigational Site, Tallinn

15006

GSK Investigational Site, A Coruña

19104

GSK Investigational Site, Philadelphia

19107

GSK Investigational Site, Philadelphia

20014

GSK Investigational Site, San Sebastián

20089

GSK Investigational Site, Rozzano (MI)

20520

GSK Investigational Site, Turku

24008

GSK Investigational Site, León

24105

GSK Investigational Site, Kiel

27599

GSK Investigational Site, Chapel Hill

27705

GSK Investigational Site, Durham

28009

GSK Investigational Site, Madrid

28033

GSK Investigational Site, Madrid

28034

GSK Investigational Site, Madrid

28040

GSK Investigational Site, Madrid

28041

GSK Investigational Site, Madrid

28050

GSK Investigational Site, Madrid

28100

GSK Investigational Site, Novara

28222

GSK Investigational Site, Majadahonda (Madrid)

28223

GSK Investigational Site, Pozuelo de Alarcón/Madrid

28911

GSK Investigational Site, Madrid

29010

GSK Investigational Site, Málaga

30008

GSK Investigational Site, Murcia

30120

GSK Investigational Site, Murcia (El Palmar)

30510

GSK Investigational Site, Krakow

31096

GSK Investigational Site, Hafia

33006

GSK Investigational Site, Oviedo

33081

GSK Investigational Site, Aviano (PN)

33100

GSK Investigational Site, Udine

33520

GSK Investigational Site, Tampere

33604

GSK Investigational Site, Pessac

34295

GSK Investigational Site, Montpellier

34481

GSK Investigational Site, Istanbul

38043

GSK Investigational Site, Grenoble

39008

GSK Investigational Site, Santander

40536

GSK Investigational Site, Lexington

40705

GSK Investigational Site, Taichung

42551

GSK Investigational Site, Velbert

44124

GSK Investigational Site, Cona (FE)

44195

GSK Investigational Site, Cleveland

46010

GSK Investigational Site, Valencia

46026

GSK Investigational Site, Valencia

47014

GSK Investigational Site, Meldola (FC)

47900

GSK Investigational Site, Rimini

48149

GSK Investigational Site, Münster

48201

GSK Investigational Site, Detroit

52249

GSK Investigational Site, Eschweiler

53127

GSK Investigational Site, Bonn

54449

GSK Investigational Site, Marshfield

55455

GSK Investigational Site, Minneota

55905

GSK Investigational Site, Rochester

56000

GSK Investigational Site, Kuala Lumpur

57010

GSK Investigational Site, Thessaloniki

63003

GSK Investigational Site, Clermont-Ferrand

66205

GSK Investigational Site, Westwood

68167

GSK Investigational Site, Mannheim

69120

GSK Investigational Site, Heidelberg

75246

GSK Investigational Site, Dallas

76038

GSK Investigational Site, Rouen

80045

GSK Investigational Site, Aurora

81545

GSK Investigational Site, Munich

91010

GSK Investigational Site, Duarte

91120

GSK Investigational Site, Jerusalem

94010

GSK Investigational Site, Créteil

94143

GSK Investigational Site, San Francisco

95445

GSK Investigational Site, Bayreuth

97080

GSK Investigational Site, Würzburg

98108

GSK Investigational Site, Seattle

125101

GSK Investigational Site, Moscow

185019

GSK Investigational Site, Petrozavodsk

191024

GSK Investigational Site, St'Petersburg

194291

GSK Investigational Site, Saint Petersburg

197110

GSK Investigational Site, Saint Petersburg

540042

GSK Investigational Site, Târgu Mureş

630099

GSK Investigational Site, Novosibirsk

02111

GSK Investigational Site, Boston

02114

GSK Investigational Site, Boston

02115

GSK Investigational Site, Boston

07601

GSK Investigational Site, Hackensack

98109-1024

GSK Investigational Site, Seattle

Unknown

GSK Investigational Site, Sofia

GSK Investigational Site, Hradec Králové

GSK Investigational Site, Hong Kong

GSK Investigational Site, Tuenmen

GSK Investigational Site, Ravenna

GSK Investigational Site, Panama City

GSK Investigational Site, Plumstead

GSK Investigational Site, Madrid

GSK Investigational Site, Ankara

GSK Investigational Site, Izmir

V5Z 1M9

GSK Investigational Site, Vancouver

E2L 4L2

GSK Investigational Site, Saint John

M5G 2M9

GSK Investigational Site, Toronto

H2L 4M1

GSK Investigational Site, Montreal

G1J 1Z4

GSK Investigational Site, Québec

S7N 4H4

GSK Investigational Site, Saskatoon

775 20

GSK Investigational Site, Olomouc

100 34

GSK Investigational Site, Prague

128 08

GSK Investigational Site, Prague

00029

GSK Investigational Site, Helsinki

106 76

GSK Investigational Site, Athens

115 27

GSK Investigational Site, Athens

151 23

GSK Investigational Site, Athens

811-1395

GSK Investigational Site, Fukuoka

377-0280

GSK Investigational Site, Gunma

737-0023

GSK Investigational Site, Hiroshima

739-0651

GSK Investigational Site, Hiroshima

650-0047

GSK Investigational Site, Hyōgo

860-0008

GSK Investigational Site, Kumamoto

856-8562

GSK Investigational Site, Nagasaki

951-8566

GSK Investigational Site, Niigata

700-8558

GSK Investigational Site, Okayama

701-1192

GSK Investigational Site, Okayama

411-8777

GSK Investigational Site, Shizuoka

113-8677

GSK Investigational Site, Tokyo

68000 Ampang

GSK Investigational Site, Kuala Selangor

2333 ZA

GSK Investigational Site, Leiden

44-101

GSK Investigational Site, Gliwice

02-776

GSK Investigational Site, Warsaw

022328

GSK Investigational Site, Bucharest

030171

GSK Investigational Site, Bucharest

105 229

GSK Investigational Site, Moscow

0181

GSK Investigational Site, Groenkloof

0001

GSK Investigational Site, Moreleta Park, Pretoria

700-721

GSK Investigational Site, Daegu

405-760

GSK Investigational Site, Incheon

519-809

GSK Investigational Site, Jellanamdo

561-712

GSK Investigational Site, Jeonju

410-769

GSK Investigational Site, Kyunggi-do

110-744

GSK Investigational Site, Seoul

120-752

GSK Investigational Site, Seoul

135-710

GSK Investigational Site, Seoul

137-701

GSK Investigational Site, Seoul

08916

GSK Investigational Site, Badalona/Barcelona

08025

GSK Investigational Site, Barcelona

08035

GSK Investigational Site, Barcelona

08036

GSK Investigational Site, Barcelona

06100

GSK Investigational Site, Ankara

06500

GSK Investigational Site, Ankara

ML6 0JS

GSK Investigational Site, Airdrie

SN3 6BB

GSK Investigational Site, Swindon

BH7 7DW

GSK Investigational Site, Bournemouth

HU16 5JQ

GSK Investigational Site, Cottingham

OX3 7LE

GSK Investigational Site, Headington, Oxford

LS9 7TF

GSK Investigational Site, Leeds

M13 9WL

GSK Investigational Site, Manchester

M20 4BX

GSK Investigational Site, Manchester

Sponsors

Lead Sponsor

All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY

NCT01610414 - Study to Evaluate Efficacy, Safety, and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Vaccine GSK1437173A | Biotech Hunter | Biotech Hunter